Status and phase
Conditions
Treatments
About
To investigate safety, tolerability, and pharmacokinetics (PK) of single i.v. doses of BI 1744 CL
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
The following exclusion criteria are specific for this study due to the known class side effect profile of ß2-mimetics:
Primary purpose
Allocation
Interventional model
Masking
64 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal